Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clopidogrel vs Warfarin for Secondary Prevention of APS-related Stroke
NCT05995600Phase 4Active, not recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Feb 2024
- Primary completion
- Jun 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clopidogrel in ischemic stroke, antiphospholipid syndrome (APS), sponsored by Seoul National University Hospital. Started Feb 2024; status: active, not recruiting.
02
Drugs
clopidogrel
03
Conditions
ischemic strokeantiphospholipid syndrome (APS)
Beyond the preview
Go deeper on NCT05995600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05995600.